These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. ML 3000 reduces gastric prostaglandin synthesis without causing mucosal injury. Wallace JL; Carter L; McKnight W; Tries S; Laufer S Eur J Pharmacol; 1994 Dec; 271(2-3):525-31. PubMed ID: 7705453 [TBL] [Abstract][Full Text] [Related]
10. Tissue-selective inhibition of prostaglandin synthesis in rat by tepoxalin: anti-inflammatory without gastropathy? Wallace JL; McCafferty DM; Carter L; McKnight W; Argentieri D Gastroenterology; 1993 Dec; 105(6):1630-6. PubMed ID: 8253339 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the anti-inflammatory effect and gastrointestinal tolerability of aceclofenac and diclofenac. Arañó A; Zapatero MI; Basi N; Duque A; Gropper S Arzneimittelforschung; 1996 Apr; 46(4):398-400. PubMed ID: 8740087 [TBL] [Abstract][Full Text] [Related]
13. Effects on intestinal microflora, gastrointestinal tolerability and antiinflammatory efficacy of diclofenac and nitrofenac in adjuvant arthritic rats. Cuzzolin L; Conforti A; Donini M; Adami A; Del Soldato P; Benoni G Pharmacol Res; 1994; 29(1):89-97. PubMed ID: 8202446 [TBL] [Abstract][Full Text] [Related]
14. Gastroprotective and safety effects of WIN-34B, a novel treatment for osteoarthritis, compared to NSAIDs. Huh JE; Lee WI; Seo BK; Baek YH; Lee JD; Choi DY; Park DS J Ethnopharmacol; 2011 Sep; 137(2):1011-7. PubMed ID: 21782922 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the ulcerogenic properties of tepoxalin with those of non-steroidal anti-inflammatory drugs (NSAIDs). Wallace JL; Cirino G; Cicala C; Anderson DW; Argentieri D; Capetola RJ Agents Actions; 1991 Sep; 34(1-2):247-50. PubMed ID: 1793039 [TBL] [Abstract][Full Text] [Related]
17. Irritation of gastrointestinal mucosa by new glycosyl derivative of diclofenac in comparison with diclofenac in rats. Borowiecka J; Pakulska W; Graczyk J; Wagrowska-Danilewicz M Acta Pol Pharm; 2000 Nov; 57 Suppl():99-102. PubMed ID: 11293281 [TBL] [Abstract][Full Text] [Related]
18. Dietary nitrate increases gastric mucosal blood flow and mucosal defense. Petersson J; Phillipson M; Jansson EA; Patzak A; Lundberg JO; Holm L Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G718-24. PubMed ID: 17082222 [TBL] [Abstract][Full Text] [Related]
19. SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions. Kim JH; Rhee HI; Jung IH; Ryu K; Jung K; Han CK; Kwak WJ; Cho YB; Joo HJ Life Sci; 2005 Jul; 77(11):1181-93. PubMed ID: 15935401 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological characterization of a novel nitric oxide-releasing diclofenac derivative containing a benzofuroxan moiety. de Carvalho PS; Maróstica M; Gambero A; Pedrazzoli J Eur J Med Chem; 2010 Jun; 45(6):2489-93. PubMed ID: 20227145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]